NU SKIN ENTERPRISES, INC. Cost of Revenue
NU SKIN ENTERPRISES, INC. (NUS) reported Cost of Revenue of $101.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $101.79M, a 15.46% decline year-over-year.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $106.14M, a 9.69% decline year-over-year.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $108.34M, a 34.89% decline year-over-year.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $107.49M, a 16.47% decline year-over-year.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for fiscal 2025 was $453.76M, a 17.53% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for fiscal 2024 was $550.23M, a 10.07% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for fiscal 2023 was $611.85M, a 3.02% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. cost of goods and services sold for fiscal 2022 was $630.91M, a 6.56% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $101.79M 10-Q · filed 2026-08-10 | $207.93M 10-Q · filed 2026-08-10 | $316.27M derived: sum of 3 quarters · filed 2026-08-10 | $423.76M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $106.14M 10-Q · filed 2026-05-08 | $214.48M derived: sum of 2 quarters · filed 2026-05-08 | $321.97M derived: sum of 3 quarters · filed 2026-05-08 | $442.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $108.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $215.83M derived: sum of 2 quarters · filed 2026-02-13 | $336.23M derived: sum of 3 quarters · filed 2026-08-10 | $453.76M 10-K · filed 2026-02-13 |
| 2025-09-30 | $107.49M 10-Q · filed 2025-11-07 | $227.89M derived: sum of 2 quarters · filed 2026-08-10 | $345.42M 10-Q · filed 2025-11-07 | $511.83M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $120.41M 10-Q · filed 2026-08-10 | $237.93M 10-Q · filed 2026-08-10 | $404.34M derived: sum of 3 quarters · filed 2026-08-10 | $533.02M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $117.53M 10-Q · filed 2026-05-08 | $283.93M derived: sum of 2 quarters · filed 2026-05-08 | $412.62M derived: sum of 3 quarters · filed 2026-05-08 | $544.52M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $166.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $295.09M derived: sum of 2 quarters · filed 2026-02-13 | $426.99M derived: sum of 3 quarters · filed 2026-02-13 | $550.23M 10-K · filed 2026-02-13 |
| 2024-09-30 | $128.68M 10-Q · filed 2025-11-07 | $260.59M derived: sum of 2 quarters · filed 2025-11-07 | $383.83M 10-Q · filed 2025-11-07 | $520.04M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $131.90M 10-Q · filed 2025-08-08 | $255.15M 10-Q · filed 2025-08-08 | $391.36M derived: sum of 3 quarters · filed 2026-02-13 | $597.87M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $123.24M 10-Q · filed 2025-05-09 | $259.46M derived: sum of 2 quarters · filed 2026-02-13 | $465.96M derived: sum of 3 quarters · filed 2026-02-13 | $601.50M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $136.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $342.72M derived: sum of 2 quarters · filed 2026-02-13 | $478.26M derived: sum of 3 quarters · filed 2026-02-13 | $611.85M 10-K · filed 2026-02-13 |
| 2023-09-30 | $206.50M 10-Q · filed 2024-11-08 | $342.05M derived: sum of 2 quarters · filed 2024-11-08 | $475.63M 10-Q · filed 2024-11-08 | $623.45M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $135.54M 10-Q · filed 2024-08-09 | $269.13M 10-Q · filed 2024-08-09 | $416.95M derived: sum of 3 quarters · filed 2025-02-14 | $590.45M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $133.59M 10-Q · filed 2024-05-09 | $281.40M derived: sum of 2 quarters · filed 2025-02-14 | $454.90M derived: sum of 3 quarters · filed 2025-02-14 | $603.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $147.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $321.32M derived: sum of 2 quarters · filed 2025-02-14 | $469.42M derived: sum of 3 quarters · filed 2025-02-14 | $630.91M 10-K · filed 2025-02-14 |
| 2022-09-30 | $173.50M 10-Q · filed 2023-11-02 | $321.60M derived: sum of 2 quarters · filed 2023-11-02 | $483.10M 10-Q · filed 2023-11-02 | $656.87M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $148.10M 10-Q · filed 2023-08-02 | $309.60M 10-Q · filed 2023-08-02 | $483.37M derived: sum of 3 quarters · filed 2024-02-15 | $642.28M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $161.50M 10-Q · filed 2023-05-04 | $335.27M derived: sum of 2 quarters · filed 2024-02-15 | $494.18M derived: sum of 3 quarters · filed 2024-02-15 | $666.16M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $173.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $332.68M derived: sum of 2 quarters · filed 2024-02-15 | $504.66M derived: sum of 3 quarters · filed 2024-02-15 | $675.22M 10-K · filed 2024-02-15 |
| 2021-09-30 | $158.91M 10-Q · filed 2022-11-03 | $330.88M derived: sum of 2 quarters · filed 2022-11-03 | $501.45M 10-Q · filed 2022-11-03 | $696.20M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $171.97M 10-Q · filed 2022-08-05 | $342.54M 10-Q · filed 2022-08-05 | $537.29M derived: sum of 3 quarters · filed 2023-02-16 | $720.67M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $170.57M 10-Q · filed 2022-05-05 | $365.32M derived: sum of 2 quarters · filed 2023-02-16 | $548.69M derived: sum of 3 quarters · filed 2023-02-16 | $702.80M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $194.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $378.13M derived: sum of 2 quarters · filed 2023-02-16 | $532.24M derived: sum of 3 quarters · filed 2023-02-16 | $658.03M 10-K · filed 2023-02-16 |
| 2020-09-30 | $183.37M 10-Q · filed 2021-11-04 | $337.48M derived: sum of 2 quarters · filed 2021-11-04 | $463.28M 10-Q · filed 2021-11-04 | $603.84M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $154.11M 10-Q · filed 2021-08-05 | $279.90M 10-Q · filed 2021-08-05 | $420.47M derived: sum of 3 quarters · filed 2022-02-16 | $560.63M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $125.79M 10-Q · filed 2021-05-05 | $266.36M derived: sum of 2 quarters · filed 2022-02-16 | $406.52M derived: sum of 3 quarters · filed 2022-02-16 | $560.55M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $140.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $280.73M derived: sum of 2 quarters · filed 2022-02-16 | $434.76M derived: sum of 3 quarters · filed 2022-02-16 | $581.42M 10-K · filed 2022-02-16 |
| 2019-09-30 | $140.16M 10-Q · filed 2020-11-05 | $294.19M derived: sum of 2 quarters · filed 2020-11-05 | $440.85M 10-Q · filed 2020-11-05 | $602.71M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $154.03M 10-Q · filed 2020-08-06 | $300.69M 10-Q · filed 2020-08-06 | $462.55M derived: sum of 3 quarters · filed 2021-02-11 | $620.00M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $146.66M 10-Q · filed 2020-05-07 | $308.52M derived: sum of 2 quarters · filed 2021-02-11 | $465.97M derived: sum of 3 quarters · filed 2021-02-11 | $634.52M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $161.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $319.31M derived: sum of 2 quarters · filed 2021-02-11 | $487.86M derived: sum of 3 quarters · filed 2021-02-11 | $634.14M 10-K · filed 2021-02-11 |
| 2018-09-30 | $157.46M 10-Q · filed 2019-11-06 | $326.01M derived: sum of 2 quarters · filed 2019-11-06 | $472.29M 10-Q · filed 2019-11-06 | $620.75M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $168.55M 10-Q · filed 2019-08-07 | $314.83M 10-Q · filed 2019-08-07 | $463.29M derived: sum of 3 quarters · filed 2020-02-13 | $584.12M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $146.28M 10-Q · filed 2019-05-01 | $294.74M derived: sum of 2 quarters · filed 2020-02-13 | $415.57M derived: sum of 3 quarters · filed 2020-02-13 | $537.09M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $148.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $269.29M derived: sum of 2 quarters · filed 2020-02-13 | $390.81M derived: sum of 3 quarters · filed 2020-02-13 | $502.08M 10-K · filed 2020-02-13 |
| 2017-09-30 | $120.83M 10-Q · filed 2018-11-08 | $242.35M derived: sum of 2 quarters · filed 2018-11-08 | $353.62M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $121.52M 10-Q · filed 2018-08-03 | $232.79M 10-Q · filed 2018-08-03 | ||
| 2016-12-31 | $500.46M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |